Citation data

CrossRef

Works that cite this article, indexed by Crossref.

19 resultsUpdated October 25, 2026
1

Regulatory T-cell remodeling across the HBV infection–cirrhosis continuum

Frontiers in Immunology 17 (2026)

Yudan Fu; Yi Wang; Jiqi Ouyang; Wenliang Lv

2

Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment

Scientific Reports 6(1) (2016)

Renyong Guo; Hejun Mao; Xiao Hu; Nengneng Zheng; Dong Yan; Jianqin He; Jiezuan Yang

4

Role of Tim-3 in hepatitis B virus infection: An overview

World Journal of Gastroenterology 22(7) (2016)

Yuan Liu; Li-Fen Gao; Xiao-Hong Liang; Chun-Hong Ma

6

FoxP3, PD-1 and CTLA-4 are Decreased Significantly After a Tenofovir Therapy in Patients With Chronic Hepatitis B

Future Virology 15(4) (2020)

Hyosun Cho; Hyojeung Kang; Ji Y Kim; Hee Y Kim; Chang W Kim

7

Predictive value of Th17 and Treg cells at baseline for HBsAg loss in chronic hepatitis B patients with low HBsAg quantification treated with pegylated interferon and nucleos(t)ide analogue

Liver Research 7(2) (2023)

Li-Li Wu; Xiao-Yan Li; Kai Deng; Bing-Liang Lin; Hong Deng; Dong-Ying Xie; Geng-Lin Zhang; Qi-Yi Zhao; Zhi-Shuo Mo; Yue-Hua Huang; Zhi-Liang Gao

8

The Influences of Antiviral Therapy on T-cell Function in Adult Patients with Chronic Hepatitis B

Future Virology 9(10) (2014)

Soeradj Harkisoen; Steven Kroon; Karel J van Erpecum; Andy IM Hoepelman; Debbie van Baarle; Joop E Arends

10

Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate

F1000Research 11 (2023)

Darmadi Darmadi; Dharma Lindarto; Jelita Siregar; Tri Widyawati; Muhammad Rusda; Mustafa Mahmud Amin; Fauzi Yusuf; Putri Chairani Eyanoer; Masrul Lubis; Imelda Rey

11

Interleukin-35 modulates the balance between viral specific CD4+CD25+CD127dim/- regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection

Virology Journal 16(1) (2019)

Lanlan Yang; Shengnan Jia; Xue Shao; Siqi Liu; Qian Zhang; Jie Song; Wudong Wang; Zhenjing Jin

12

Circulating IL-1β, IL-17, and IP-10 as Potential Predictors of Hepatitis B Virus Infection Prognosis

Journal of Immunology Research 2022 (2022)

Zhenzhen Su; Jie Chen; Junlong Zhang; Yunfei An; Yun Liao; Xiaojuan Wu; Chuanmin Tao; Lanlan Wang; Bei Cai; Dawei Cui

13

Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate

F1000Research 11 (2022)

Darmadi Darmadi; Dharma Lindarto; Jelita Siregar; Tri Widyawati; Muhammad Rusda; Mustafa Mahmud Amin; Fauzi Yusuf; Putri Chairani Eyanoer; Masrul Lubis; Imelda Rey

14

Changes of cytokine levels and T cell surface molecules in patients with chronic hepatitis B and the association with functional cure

Journal of Medical Virology 93(8) (2021)

Zhen Xu; Ji‐zong Lin; Ying‐fu Zeng; Xiao‐hua Yang; Zhe‐bin Wu; Zhao‐xia Hu; Qi‐yi Zhao; Jing Liu; Zhi‐liang Gao

15

Langzeittherapie der HBV-Infektion mit oralen Polymeraseinhibitoren

Der Gastroenterologe 10(4) (2015)

F. van Bömmel; T. Berg

16

The Effects of Nucleoside/Nucleotide Analogues on Host Immune Cells: The Baseline for Future Immune Therapy for HBV?

Antiviral Therapy 25(4) (2020)

Lauke L Boeijen; Michelle Spaan; André Boonstra

17

Cytokines and Chemokines in HBV Infection

Frontiers in Molecular Biosciences 8 (2021)

Shihong Zhong; Tianling Zhang; Libo Tang; Yongyin Li

18

Sustained Changes of Treg and Th17 Cells During Interferon-α Therapy in Patients with Chronic Hepatitis B

Viral Immunology 28(8) (2015)

Hao Feng; Jie Yin; Ya-Ping Han; Xiao-Ying Zhou; Su Chen; Li Yang; Jin-Rui Yan; Guo-Xin Zhang

19

Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study

Journal of Hepatology 68(6) (2018)

Shishu Zhu; Hongfei Zhang; Yi Dong; Limin Wang; Zhiqiang Xu; Weiwei Liu; Yu Gan; Hongmei Tang; Dawei Chen; Fuchuan Wang; Pan Zhao